Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04847102
Brief Title: A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above

First Submitted : April 13, 2021
First Submitted that Met QC Criteria : April 13, 2021
First Posted : April 15, 2021

Last Update Submitted that Met QC Criteria : November 10, 2021
Last Update Posted : November 18, 2021